First-pass extracted concept

HPV L1 pentamer to VLP assembly under oxygen supplementation

Candidate: concept label1 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

The paper studies an oxygen-adjusted assembly condition for converting HPV L1 pentamers into complete VLPs during vaccine production. The reported effect is faster assembly and higher in vitro relative potency.

Source 1DOI PubMed

Resources required

The abstract indicates use of HPV L1 pentamers from types 6, 33, and 45 plus an assembly process with and without oxygen supplementation. It also requires analytical readouts including particle size, antigen relative potency, HPLC purity, disulfide bond content, and disulfide bond ratio.

Source 1DOI PubMed

What problem it solves

It addresses process control of HPV VLP assembly, where structural stability, homogeneity, and potency are important for vaccine efficacy. The reported benefit is accelerated assembly into complete VLPs with improved potency.

Source 1DOI PubMed

What it does not solve

The abstract does not show that oxygen supplementation alone solves all quality attributes such as thermal stability or immunogenicity in vivo. It also does not define exact operating conditions or type-specific limits.

Source 1DOI PubMed

Alternatives

The abstract contrasts oxygen supplementation against a control condition without oxygen supplementation. No other assembly-optimization strategy is explicitly compared in the source abstract.

Source 1DOI PubMed

Evidence Snippets

This study investigated the effect of oxygen concentration on VLPs assembly using L1 pentamers of HPV types 6, 33, and 45.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1manufacturing optimizationsupports2025Source 1DOI PubMed

The oxygen-supplemented assembly findings were validated at a commercial production base and led to optimized HPV vaccine manufacturing processes and improved vaccine potency.

Quoted textsource-backed

These findings were further validated at the Kunming Commercial Production Base, leading to optimized HPV vaccine manufacturing processes and improved vaccine potency.

Claim 2mechanistic effectsupports2025Source 1DOI PubMed

Increased oxygen concentration significantly accelerated assembly of HPV L1 pentamers into complete VLPs.

Quoted textsource-backed

Results demonstrated that increased oxygen concentration significantly accelerated the assembly of L1 pentamers into complete VLPs

Claim 3performance improvementsupports2025Source 1DOI PubMed

Increased oxygen concentration enhanced in vitro relative potency of HPV VLPs.

Quoted textsource-backed

and enhanced their in vitro relative potency